Investment
Features
FeesSafety
Academy
More
Pluang+

Ethereum ETFs surpass Bitcoin ETFs in September inflows, driven by staking and institutional interest.

Market News
15 Sep 2026
Crypto Briefing
View Source
Bullish
Ethereum ETFs surpass Bitcoin ETFs in September inflows, driven by staking and institutional interest.

In September 2026, Ethereum ETFs attracted more net inflows than Bitcoin ETFs, marking a rare reversal in crypto ETF trends. Ethereum ETFs pulled in about $445 million for the month, slightly below Bitcoin's $467 million but showing stronger momentum mid-month. This shift is attributed to Ethereum's staking features, which offer yield opportunities not available with Bitcoin ETFs, appealing to institutional investors. The trend follows a strong August for Ethereum ETFs and reflects a broader rotation amid macroeconomic uncertainty and active marketing by major issuers like BlackRock and Fidelity.

Ethereum ETF inflows in September 2026 provide context for crypto markets, with Pluang data as of Sep 15, 2026 17:31 WIB showing that among 50 major cryptocurrencies, 13 rose and 36 fell today. Notable movers include VET at Rp130 with a 1-day change of -5.94% and a Pluang order activity of 99% Sell, XNO at Rp5.626 with -5.73% and 62% Buy activity, and UNI at Rp117.553 with +5.55% and balanced buy/sell orders. The most notable figure today is VET's 99% sell order activity.

More News

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...

Company Fundamentals
Bullish
55 minutes ago
Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...

Analyst Insights
Bullish
1 hour ago
GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Market News
Bullish
2 hours ago
NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

BNP Paribas Exane raised NVIDIA's price target from $285 to $345 due to strong demand for its AI chips, signaling potential upside of about 45.6% from the current price. NVIDIA shares have gained about 25% in 2026, driven by growth in AI infrastructu...

Analyst Insights
Bullish
3 hours ago
Bitcoin hits predicted peak of $126K on Oct 6, 2025; next bottom forecasted for Oct 5, 2026 near $86K.

Bitcoin hits predicted peak of $126K on Oct 6, 2025; next bottom forecasted for Oct 5, 2026 near $86K.

A 4chan post from December 2023 accurately predicted Bitcoin's all-time high of around $126,000 on October 6, 2025, based on a 364-day market cycle pattern. Following the peak, Bitcoin dropped about 52% by mid-2026 but has since recovered to roughly ...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App